Now I have all the context needed. Let me write the consolidated review.

## Summary

This paper challenges the prevailing sequence-centric paradigm for Scientific LLMs (Sci-LLMs) by proposing that feeding models high-level structured context (from bioinformatics tools like InterProScan, BLASTp) is more effective than feeding raw biomolecular sequences. Through systematic experiments across specialized Sci-LLMs (Intern-S1, Evolla, NatureLM) and general LLMs (DeepSeek-v3, Gemini, GPT-5, Qwen3), the authors show that context-only input consistently matches or outperforms sequence+context, while being dramatically cheaper and faster. The core finding — that current Sci-LLMs benefit more from reasoning over structured knowledge than from direct sequence interpretation — is practically significant and well-motivated.

---

## Strengths

1. **Clear, counter-intuitive central hypothesis with broad practical implications.** The paper proposes that context from bioinformatics tools (BLAST, InterProScan, Pfam) is sufficient for protein understanding and that raw sequences add little or no value — even for specialized Sci-LLMs built to process them. This is a well-motivated, non-obvious claim that, if supported, would reshape how the community designs scientific AI systems. The finding that context-only outperforms sequence+context across all three *specialized* Sci-LLMs tested (Intern-S1, Evolla, NatureLM) is striking and directly supports this hypothesis.

2. **Comprehensive experimental scope.** The paper evaluates across (i) a multi-task benchmark (function, pathway, subcellular localization), (ii) representation analysis (t-SNE + ARI), (iii) temporal robustness analysis, (iv) efficiency comparison, and (v) wet-lab validation on truly novel proteins. This breadth strengthens the paper relative to narrower studies and makes the practical finding more actionable.

3. **Temporal and efficiency analyses provide concrete, practically useful evidence.** The temporal analysis (Figure 4) showing that Evolla's performance degrades sharply for recently discovered proteins (slope -0.923) while the context-driven approach degrades more gracefully (slope -0.618) is informative. The efficiency numbers (Table 2: 30× cheaper, 154× faster than Evolla at batch scale) make a compelling practical case.

4. **Wet-lab validation on truly novel proteins.** The use of unpublished sequences absent from public databases provides a genuine out-of-distribution test that benchmarks alone cannot offer. Our method achieving 100%/97.3% on Rhodopsin/PETase (per Figure 5) is strong positive evidence for the context-driven approach's generalization capability.

---

## Weaknesses

### Fatal
None.

### Major

1. **Internal contradiction in wet-lab validation undermines the Evolla comparison.** The main text (line 262) states: "Evolla (Figure 6) attains a reasonable 80.0% accuracy on Rhodopsin, it fails catastrophically on PETase." However, Figure 6 caption reports Evolla achieving **5.00%** (1/20) on Rhodopsin and **83.78%** (31/37) on PETase. The text and figure directly contradict each other on both accuracy values and which family is the "failure." This is not a formatting issue — it is a factual inconsistency about the experimental results of a central comparison. The authors must clarify which numbers are correct and, if it is indeed 5% on a binary task, explain the anomaly rather than attributing it to "training data bias." This inconsistency erodes confidence in the wet-lab section.

2. **The "consistent degradation" claim is overstated in the abstract and takeaways.** The paper's most prominent claims — the abstract says "the inclusion of the raw sequence alongside its high-level context consistently degrades performance" and the Section 5.1 takeaway says sequences "consistently act as informational noise" — are not supported by Table 1. For 3 of the 4 general LLMs (DeepSeek-v3, GPT-5, Qwen3), Seq+Context slightly *improves* over Context-Only (e.g., DeepSeek: 86.03 vs 84.99; Qwen3: 85.90 vs 84.99). The pattern holds for the 3 specialized Sci-LLMs, so the paper should frame this as a mixed result — "context alone is competitive or superior, particularly for specialized models" — rather than a universal phenomenon.

3. **Representation analysis (Figures 2 and 3) compares fundamentally different quantities.** The "Ours" embeddings in Figure 2d are generated from the *textual context* using Qwen-embedding — a separate text embedding model — while the Sci-LLM embeddings (Figures 2a–c) are the models' own final-layer representations after processing raw sequences. The context text explicitly contains functional terms (e.g., "kinase domain," "ATP binding"), so near-perfect functional separation (ARI 0.958) is expected and partly tautological. A fairer comparison would use the same embedding source across all conditions (e.g., final-layer representations from the same LLM given different inputs). This does not invalidate the paper's core claim, but the presentation overstates the "weak representation" argument.

4. **No error bars, confidence intervals, or significance tests on any quantitative result.** Table 1 reports scores to two decimal places without any indication of variance. The temporal analysis (Figure 4) reports slopes without confidence intervals. The representation analysis reports ARI as point estimates. For a study making comparative claims about different input modalities, the lack of statistical grounding means the reader cannot assess whether observed differences (e.g., Context-Only 86.15 vs Seq+Context 84.03 for Intern-S1) are reliable. This is standard for large-scale LLM benchmarks in this subfield, but it limits the precision of the paper's conclusions.

### Minor

1. **The LLM-Score metric is not validated in the main text.** Performance is quantified by "a general-purpose LLM as an expert judge" (the LLM-Score). The rubric, prompt, and any validation against human judgment are deferred to the appendix (stripped from the review copy). While LLM-as-judge is common practice, the paper's central quantitative comparisons rest on this metric, and the main text should provide at least a summary of the evaluation protocol and evidence of reliability.

2. **Dataset details are absent from the main text.** The number of proteins per task, selection criteria, and filtering methodology are referenced to appendices. The reader cannot assess the scale or representativeness of the evaluation from the main text alone.

### Trivial
None.

---

## Nice-to-Haves

- **Include confidence intervals via bootstrapping** for the main comparisons in Table 1 and the temporal slopes in Figure 4. This would directly address the most common concern about evaluation reliability.
- **Validate the LLM-Score** by reporting agreement (e.g., Cohen's κ) on a sample against human expert annotators, even if only on 50–100 responses.
- **Compute embeddings from the same LLM** (e.g., DeepSeek-v3's final layer) across all input conditions for the representation analysis, to enable a fair apple-to-apple comparison of the models' internal representations.

---

## Removed Points

These points are flagged for removal; treat with caution.

- *Harsh critic's claim that the Evolla Rhodopsin 5% result "strongly suggests a data processing or tokenization failure" and should be removed.* This is a specific diagnostic claim that goes beyond what can be verified from the paper. The 5% figure does exist in the figure caption (though it conflicts with the text), and it is a legitimate point to flag, but the critic's specific diagnosis ("tokenization failure") is speculation. However, the *internal inconsistency* between text and figure is a verified fact and is retained as a Major weakness.
- *Harsh critic's point about label leakage via BLASTp needing more detail.* This is a reasonable question but the paper explicitly states it restricts to homolog annotations rather than the query's own record, and the filtering details are in the appendix. Lacking access to the appendix, this is not a verifiable weakness of the main text.
- *Strength Finder's claim that "context-only consistently beats sequence+context across all models."* This is factually incorrect (3 general LLMs show improvement), and the editorial rules state that when a strength and verified weakness conflict, the weakness wins. Removed.

---

## Novel Insights

None beyond the paper's own contributions.

---

## Suggestions

1. **Fix the internal contradiction in Section 5.6.** Verify whether the text or the figure captions are correct for Evolla's wet-lab performance. If the figure is correct (5% on Rhodopsin), provide a concrete investigation of why — tokenization mismatch, format incompatibility, or genuine failure. If the text is correct, correct the figure captions.
2. **Reframe the central claim** from "sequences consistently degrade performance" to "context alone is competitive or superior to sequence+context, and is dramatically more efficient; for specialized Sci-LLMs, adding sequence to context is consistently detrimental." This is more accurate and still impactful.
3. **Add a simple statistical analysis** — at minimum, bootstrap confidence intervals for the overall scores in Table 1.
4. **Include a brief summary of the LLM-Score evaluation protocol** (prompt template, rubric dimensions) in the main text, even if just 3–5 lines, so the reader can assess the metric's face validity without consulting the appendix.

---

## Score and Decision

### Calibration Report

**Round 1 (Bracketing):**
- Weak band (<3.5): Papers on protein evaluation metrics (avg 3.0–3.4), G2T-LLM for molecules (3.0), ProteinAdapter (3.4). These are reject-level papers with thin experiments or unclear contributions. **This paper is clearly stronger.**
- Middle band (3.5–7.5): LLaPA (4.75), LLaPA for PPI (6.00), STELLA (5.83), ProteinWorkshop (6.25). These papers have clearer contributions but also methodological weaknesses.
- Strong band (>7.5): LLM-SR (8.0), Knowledge Card (8.0), safety alignment paper (9.5). **This paper is not in this range** — it lacks the rigor, validation depth, and clean narratives of these papers.

**Round 1 bracket:** Between 5.0 and 7.0.

**Round 2 (Narrowing):**
- STELLA (5.83, Reject): Similar multimodal-LLM-for-proteins domain. Criticized for limited novelty (replacing sequence encoder with structure encoder), not beating SOTA baselines. **This paper is comparable or slightly stronger** — its core finding is more novel and counter-intuitive than STELLA's, and it has wet-lab validation STELLA lacks. But STELLA's results are internally clean, while this paper has an internal contradiction.
- CURIE (6.40, Accept): Evaluation benchmark with similar LMScore concerns and small dataset. Accepted because the benchmark itself is a contribution. **This paper is slightly weaker** — CURIE's weaknesses are about scope (small dataset) while this paper's weaknesses are about internal consistency (contradictory results).
- CASE-Bench (5.25, Reject): Thorough human annotation but questionable premise. **This paper is stronger** — the research question is better motivated.
- LLaPA for EC (4.75, Reject): Similar data leakage concerns, unclear benefit of LLM. **This paper is notably stronger** — clearer hypothesis, broader experiments.

**Final placement:** The paper sits between the ~5.8 (STELLA) and ~6.4 (CURIE) anchors. It has a stronger core finding than either but is dragged down by the internal inconsistency and overclaims. Comparable to a cleaned-up version of STELLA in quality. Score: **5.5**.

---

MY FINAL SCORE: <score>5.5</score>
MY FINAL DECISION: <decision>Reject</decision>